Literature DB >> 22348488

Kawasaki disease: an update on diagnosis and treatment.

Ho-Chang Kuo1, Kuender D Yang, Wei-Chiao Chang, Luo-Ping Ger, Kai-Sheng Hsieh.   

Abstract

Kawasaki disease (KD) is an acute multi-system vasculitis syndrome of unknown etiology occurring mostly in infants and children younger than 5 years of age. In developed countries, it is the leading cause of acquired heart disease in children. However, KD remains a mysterious disease. Some viruses potentially causing the condition have been isolated, but the results have not been able to be reproduced. This article reviews and summarizes different aspects of KD and provides updated information on diagnosis and treatment. The supplementary criteria for incomplete presentation of KD patients suggested by the American Heart Association, treatment (including tumor necrosis factor-alpha antagonist, methylprednisolone pulse therapy, statins, plasma exchange, and cytotoxic agents) for those with intravenous immunoglobulin treatment failure, and other experiences are also included in this review.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22348488     DOI: 10.1016/j.pedneo.2011.11.003

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  50 in total

1.  The factors affecting the disease course in Kawasaki disease.

Authors:  Elif Arslanoglu Aydin; Ilker Ertugrul; Yelda Bilginer; Ezgi Deniz Batu; Hafize Emine Sonmez; Selcan Demir; Zehra Serap Arici; Erdal Sag; Dursun Alehan; Seza Ozen
Journal:  Rheumatol Int       Date:  2019-05-28       Impact factor: 2.631

2.  Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.

Authors:  Lan He; Youyu Sheng; Chunyun Huang; Guoying Huang
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

Review 3.  Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.

Authors:  Seyyedeh Saneeymehri; Katherine Baker; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

4.  Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease.

Authors:  K Ishibashi; R Fukazawa; N N Miura; Y Adachi; S Ogawa; N Ohno
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

5.  Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.

Authors:  Miyu Tajima; Yusuke Shiozawa; Jiro Kagawa
Journal:  Pediatr Cardiol       Date:  2015-03-10       Impact factor: 1.655

6.  Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study.

Authors:  H-C Kuo; W-C Chang; L-J Wang; S-C Li; W-P Chang
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-22       Impact factor: 6.892

Review 7.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

8.  Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013.

Authors:  Xiaomei Zhang; Yanyan Liang; Wanyu Feng; Xuewen Su; Hua Zhu
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

9.  Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays.

Authors:  Ho-Chang Kuo; Ying-Hsien Huang; Feng-Hsiang Chung; Po-Chung Chen; Tzu-Cheng Sung; Yi-Wen Chen; Kai-Sheng Hsieh; Chien-Sheng Chen; Guan-Da Syu
Journal:  Mol Cell Proteomics       Date:  2017-12-15       Impact factor: 5.911

10.  Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.

Authors:  Rui-Xia Song; Qing-Mei Zou; Xiao-Hui Li; Nan-Ping Xu; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-11-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.